{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:17:42Z","timestamp":1793056662733,"version":"4.5.0"},"reference-count":14,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"\n Summary<\/jats:title>\n A 67-year-old Caucasian woman with a history of Graves\u2019 disease and atrial fibrillation presented with severe symptoms indicative of an impending thyroid storm, including diarrhea, tremors, palpitations and significant weight loss. Initially treated with methimazole, she was switched to propylthiouracil (PTU) due to an allergic reaction but had to discontinue PTU after developing agranulocytosis. Laboratory tests confirmed suppressed thyroid-stimulating hormone and elevated free thyroxine (FT4) and free triiodothyronine (FT3) levels, alongside neutropenia. The medical team administered high-dose intravenous steroids and granulocyte colony-stimulating factor (G-CSF) in response to her worsening condition and to mitigate infection risk. Despite these measures, her thyroid hormone levels remained high, necessitating therapeutic plasma exchange (TPE). This intervention significantly reduced her thyroid hormone levels and thyrotropin receptor antibodies (TRAb), stabilizing her condition. Post-TPE, she underwent successful radioactive iodine therapy (RAI), which led to a gradual return to euthyroid status and substantial symptomatic relief. Three months post-RAI, she maintained a stable euthyroid state with normalized neutrophil counts, demonstrating the effectiveness of a multidisciplinary approach in managing impending thyroid storm complications. This case highlights the importance of timely and integrated therapeutic interventions in managing life-threatening endocrine emergencies.<\/jats:p>\n <\/jats:sec>\n \n Learning points<\/jats:title>\n \n \n This case highlights the importance of early recognition and management of agranulocytosis induced by antithyroid drugs, particularly in the context of Graves\u2019 disease.<\/jats:p>\n <\/jats:list-item>\n \n Therapeutic plasma exchange (TPE) can be an effective bridging therapy for rapid thyroid hormone reduction in thyroid storm, especially when conventional treatments are insufficient or contraindicated.<\/jats:p>\n <\/jats:list-item>\n \n Quick and effective intervention is essential in managing thyroid storm to prevent systemic decompensation, highlighting the importance of a timely and coordinated treatment approach.<\/jats:p>\n <\/jats:list-item>\n \n The role of TPE in managing severe hyperthyroidism underscores the need for flexibility and innovation in critical endocrine emergencies.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>","DOI":"10.1530\/edm-24-0150","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:31:23Z","timestamp":1747035083000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic plasma exchange as a bridge to definitive treatment in severe thyrotoxicosis with propylthiouracil-induced neutropenia"],"prefix":"10.1530","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-3033","authenticated-orcid":true,"given":"Sanja","family":"Medenica","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Montenegro, Podgorica, Montenegro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Prelevi\u0107","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Internal Medicine Clinic, Clinical Center of Montenegro, Podgorica, Montenegro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Tomovic","sequence":"additional","affiliation":[{"name":"Clinic for Nephrology, Clinical Center of Montenegro, Podgorica, Montenegro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-5492","authenticated-orcid":true,"given":"Vivek","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Laketi\u0107","sequence":"additional","affiliation":[{"name":"Special Hospital for Thyroid Gland and Metabolism Diseases, Zlatibor, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Baj\u010deta","sequence":"additional","affiliation":[{"name":"Intensive care unit, Internal Medicine Clinic, Clinical Centre of Montenegro, Podgorica, Montenegro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Stojkovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-1611","authenticated-orcid":true,"given":"Pinaki","family":"Dutta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Drugs R D","first-page":"91","article-title":"Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management","volume":"17","author":"Vicente N","year":"2017","unstructured":"Vicente N\n, \nCardoso L\n, \nBarros L\n, et al.\n Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management. Drugs R D 2017 17 91\u201396. (https:\/\/doi.org\/10.1007\/s40268-017-0172-1)"},{"key":"bib2","series-title":"J Pers Med","first-page":"517","article-title":"Therapeutic plasma exchange for the treatment of hyperthyroidism: approach to the patient with thyrotoxicosis or antithyroid-drugs induced agranulocytosis","volume":"13","author":"Tizianel I","year":"2023","unstructured":"Tizianel I\n, \nSabbadin C\n, \nCensi S\n, et al.\n Therapeutic plasma exchange for the treatment of hyperthyroidism: approach to the patient with thyrotoxicosis or antithyroid-drugs induced agranulocytosis. J Pers Med 2023 13 517. (https:\/\/doi.org\/10.3390\/jpm13030517)"},{"key":"bib4","series-title":"Endocr J","first-page":"695","article-title":"Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil","volume":"71","author":"Noh JY","year":"2024","unstructured":"Noh JY\n, \nInoue K\n, \nSuzuki N\n, et al.\n Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil. Endocr J 2024 71 695\u2013703. (https:\/\/doi.org\/10.1507\/endocrj.ej24-0135)"},{"key":"bib5","series-title":"Nat Commun","first-page":"7633","article-title":"Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study","volume":"6","author":"Chen PL","year":"2015","unstructured":"Chen PL\n, \nShih SR\n, \nWang PW\n, et al.\n Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat Commun 2015 6 7633. (https:\/\/doi.org\/10.1038\/ncomms8633)"},{"key":"bib6","series-title":"Int J Pediatr Endocrinol","article-title":"Adverse events associated with methimazole therapy of Graves' disease in children","volume":"2010","author":"Rivkees SA","year":"2010","unstructured":"Rivkees SA\n, \nStephenson K\n & \nDinauer C\n\n. Adverse events associated with methimazole therapy of Graves' disease in children. Int J Pediatr Endocrinol 2010 2010 176970. (https:\/\/doi.org\/10.1155\/2010\/176970)"},{"key":"bib7","series-title":"Therapie","first-page":"559","article-title":"Methimazole-induced urticaria in hyperthyroid patients: a safe re-administration protocol","volume":"79","author":"Chahed F","year":"2024","unstructured":"Chahed F\n, \nFredj NB\n, \nRomdhane HB\n, et al.\n Methimazole-induced urticaria in hyperthyroid patients: a safe re-administration protocol. Therapie 2024 79 559\u2013563. (https:\/\/doi.org\/10.1016\/j.therap.2023.12.006)"},{"key":"bib8","series-title":"Endocr Pract","first-page":"269","article-title":"Methimazole drug allergy: a possible solution using a \u201cmethimazole solution\u201d","volume":"27","author":"Cooper DS","year":"2021","unstructured":"Cooper DS\n & \nMathew A\n\n. Methimazole drug allergy: a possible solution using a \u201cmethimazole solution\u201d. Endocr Pract 2021 27 269\u2013270. (https:\/\/doi.org\/10.1016\/j.eprac.2021.01.012)"},{"key":"bib3","series-title":"J Clin Apher","first-page":"419","article-title":"Therapeutic plasma exchange for control of thyroid storm","volume":"35","author":"Tan AWK","year":"2020","unstructured":"Tan AWK\n, \nLim BSP\n, \nHoe JKM\n, et al.\n Therapeutic plasma exchange for control of thyroid storm. J Clin Apher 2020 35 419\u2013425. (https:\/\/doi.org\/10.1002\/jca.21767)"},{"key":"bib9","series-title":"Case Rep Endocrinol","article-title":"Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review of the literature","volume":"2018","author":"Garla V","year":"2018","unstructured":"Garla V\n, \nKovvuru K\n, \nAhuja S\n, et al.\n Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review of the literature. Case Rep Endocrinol 2018 2018 4135940. (https:\/\/doi.org\/10.1155\/2018\/4135940)"},{"key":"bib10","series-title":"Int J Clin Pract","first-page":"554","article-title":"Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated","volume":"58","author":"Ozbey N","year":"2004","unstructured":"Ozbey N\n, \nKalayoglu-Besisik S\n, \nGul N\n, et al.\n Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated. Int J Clin Pract 2004 58 554\u2013558. (https:\/\/doi.org\/10.1111\/j.1368-5031.2004.00140.x)"},{"key":"bib11","series-title":"J Med Case Rep","first-page":"193","article-title":"Plasmapheresis in thyrotoxicosis: a single-center case series","volume":"18","author":"Rami I","year":"2024","unstructured":"Rami I\n, \nZerrouki D\n, \nAssarrar I\n, et al.\n Plasmapheresis in thyrotoxicosis: a single-center case series. J Med Case Rep 2024 18 193. (https:\/\/doi.org\/10.1186\/s13256-024-04480-9)"},{"key":"bib12","series-title":"Eur Thyroid J","first-page":"86","article-title":"Therapeutic plasma exchange in refractory hyperthyroidism","volume":"10","author":"Sa\u00efe C","year":"2021","unstructured":"Sa\u00efe C\n, \nGhander C\n, \nSaheb S\n, et al.\n Therapeutic plasma exchange in refractory hyperthyroidism. Eur Thyroid J 2021 10 86\u201392. (https:\/\/doi.org\/10.1159\/000511060)"},{"key":"bib13","series-title":"N Engl J Med","first-page":"905","article-title":"Antithyroid drugs","volume":"352","author":"Cooper DS","year":"2005","unstructured":"Cooper DS\n\n. Antithyroid drugs. N Engl J Med 2005 352 905\u2013917. (https:\/\/doi.org\/10.1056\/NEJMra042972)"},{"key":"bib14","series-title":"JAMA","first-page":"1857","article-title":"The influence of cholestyramine on thyroxine absorption","volume":"208","author":"Northcutt RC","year":"1969","unstructured":"Northcutt RC\n, \nStiel JN\n, \nHollifield JW\n, et al.\n The influence of cholestyramine on thyroxine absorption. JAMA 1969 208 1857\u20131861. (https:\/\/doi.org\/10.1001\/jama.1969.03160100093023)"}],"container-title":["Endocrinology, Diabetes & Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2025\/2\/EDM-24-0150.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/2\/EDM-24-0150.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/2\/EDM-24-0150.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:33Z","timestamp":1784555313000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":14,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/edm-24-0150","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}